The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
one thing that it really caught our attention and we think that uh this is something that we really want to emphasize and hopefully others in the future is that we have identified that there's the mitochondrial pyit carrier which is as I discussed earlier that's the transporter of of pyu into the mitochondria which is disregulated already
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
we have identified that there's the mitochondrial pyit carrier which is as I discussed earlier that's the transporter of of pyit into the mitochondria which is um disregulated already down significantly down regulated in in sary individuals compared to um um active individuals
then we are matching it with the with flux the oxidation itself so both the transporter and the flux are significantly disregulated